The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The Future of Precision Medicine: Potential Impacts for Health Technology Assessment
Open accessAbstract
OBJECTIVE: Precision medicine allows healthcare interventions to be tailored to groups of patients based on their disease susceptibility, diagnostic or prognostic information, or treatment response. We analysed what developments are expected in precision medicine over the next decade and considered the implications for health technology assessment (HTA) agencies. METHODS: We performed a pragmatic literature search to account for the large size and wide scope of the precision medicine literature. We refined and enriched these results with a series of expert interviews up to 1 h in length, including representatives from HTA agencies, research councils and researchers designed to cover a wide spectrum of precision medicine applications and research. RESULTS: We identified 31 relevant papers and interviewed 13 experts. We found that three types of precision medicine are expected to emerge in clinical practice: complex algorithms, digital health applications and 'omics'-based tests. These are expected to impact upon each stage of the HTA process, from scoping and modelling through to decision-making and review. The complex and uncertain treatment pathways associated with patient stratification and fast-paced technological innovation are central to these effects. DISCUSSION: Innovation in precision medicine promises substantial benefits but will change the way in which some health services are delivered and evaluated. The shelf life of guidance may decrease, structural uncertainty may increase and new equity considerations will emerge. As biomarker discovery accelerates and artificial intelligence-based technologies emerge, refinements to the methods and processes of evidence assessments will help to adapt and maintain the objective of investing in healthcare that is value for money.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to genetic information, other biomarkers such as protein expression, gut microbiome, and metabolic profile are also employed with machine learning to enable personalized treatments [12].”
From The rise of artificial intelligence in healthcare applications (2020) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Omics-based tests: Genetic information from a population pool is used with machine learning algorithms to find correlations and predict treatment responses for the individual patient.”
From The rise of artificial intelligence in healthcare applications (2020) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods of data collection in qualitative research: interviews and focus groups
Gill, P., Stewart, K., Treasure, E. T., & Chadwick, B. L. (2008) · BDJ · doi:10.1038/bdj.2008.192 · Cited by 2,779
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Mahmood, S. S., Levy, D., Vasan, R. S., & Wang, T. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61752-3 · Cited by 1,622
Adapting to Artificial Intelligence: Radiologists and Pathologists as Information Specialists
Jha, S., & Topol, E. J. (2016) · JAMA · doi:10.1001/jama.2016.17438 · Cited by 622
The Precision Medicine Initiative
Ashley, E. A. (2015) · JAMA · doi:10.1001/jama.2015.3595 · Cited by 573
Risk models and scores for type 2 diabetes: systematic review
Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551
Clinical Interpretation and Implications of Whole-Genome Sequencing
Dewey, F., Grove, M. E., Pan, C., Goldstein, B., Bernstein, J., Chaib, H., Merker, J., Goldfeder, R., Enns, G., David, S., et al. (2014) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2014.1717 · Cited by 456
Brouwer, W. B. F., Culyer, A. J., van Exel, J. N. A., & Rutten, F. (2007) · Journal of Health Economics · doi:10.1016/j.jhealeco.2007.07.003 · Cited by 335
Updated UK Recommendations for HER2 assessment in breast cancer
Rakha, E. A., Pinder, S. E., Bartlett, J. M. S., Ibrahim, M., Starczynski, J., Carder, P. J., Provenzano, E., Hanby, A. M., Hales, S., Lee, A. H. S., et al. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202571 · Cited by 253
“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
Matthews, H., Hanison, J., & Nirmalan, N. J. (2016) · Proteomes · doi:10.3390/proteomes4030028 · Cited by 202
Bojke, L., Claxton, K., Sculpher, M. J., & Palmer, S. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00502.x · Cited by 186
Flagged first, then by citations
Research works printed but not linked: 9
- England NHS. 100,000 Genomes Project: paving the way to personalised medicine. London: NHS England; 2016.
- National Institute for Health and Care Excellence. Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat. London: NICE; 2013.
- Garrison L, Mestre-Ferrandiz J, Zamora B. The value of knowing and knowing the value: improving the health technology assessment of complementary diagnostics. White paper. London: Office of Health Economics, EPEMED; 2016.
- Academy of Medical Sciences. Health economics for stratified medicine. Summary of a workshop held on 5 October 2016 by the Academy of Medical Sciences and the UK Pharmacogenetics and Stratified Medicine Network. London: Academy of Medical Sciences; 2016. p. 2016.
- National Institute for Health and Care Excellence. NICE’s equality objectives and equality programme 2016–2020. London: NICE; 2016.
- National Institute for Health and Care Excellence. Evaluation consultation document—Eliglustat for treating type 1 Gaucher disease. London: NICE; 2017.
- National Institute for Health and Care Excellence. Fast track appraisal: addendum to the guide to the processes of technology appraisal. London: NICE; 2017.
- National Institute for Health and Care Excellence. Proposals for increasing capacity within NICE’s technology appraisal programme. London: NICE; 2017.
- Hutt P, Gilmour S. Tackling inequalities in general practice: an inquiry into the quality of general practice in England. London: The King’s Fund; 2010.
Cited by
Sorted by citations
Items 101–131 of 131
Use of robotics in healthcare digitalization
Bankar, N. J., Khatib, K. N., Bandre, G. R., & Kale, S. G. (2024) · AIP conference proceedings · doi:10.1063/5.0240197 · Cited by 1
Precision Medicine in View of Genomic Biomarker Discovery
Kohli, A., Verma, S., Agarwal, N., Kushwaha, A., Gupta, A., & Kumar, A. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-6597-7.ch007 · Cited by 1
Economic Evaluation of Companion and Complementary Diagnostics
Doble, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813539-6.00020-1 · Cited by 1
Innovation Ecosystems for Precision Medicine Implementation
Gong, H. (2020) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Stute, L., & Krüger, R. (2020) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1149-2204
Additive manufacturing in community pharmacies: a framework for business model innovation
Feldmann, C., & Rose, O. (2021) · BMJ Innovations · doi:10.1136/bmjinnov-2019-000416
Characteristics and therapy of advanced cancer diseases
Taghizadeh, H. (2021)
Cereceda, K., Jorquera, R., & Villarroel‐Espíndola, F. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2021-0051
Alliances: Knowledge Infrastructures, and the Digitization of Precision Health
Hays, P. V. (2021) · Springer eBooks · doi:10.1007/978-3-030-80100-7_4
Cohen, S. B., Akmaev, V. R., Withers, J. B., & Connolly-Strong, E. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00387-9
Magdy, A., Maher, M., Hasanien, S., Elhossieny, E., & Zarif, B. (2022) · doi:10.2196/preprints.38195
Role of Precision Medicine in Disease Treatment and Prevention
Bera, A. (2021) · Journal of Pharmaceutical Research and Innovation · doi:10.36647/jpri/01.01.a005
Electronic Health Records to Detect Psychosis Risk
Oliver, D., & Fusar‐Poli, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-10698-9_12
Sayer, M. (2023) · Chapman University Digital Commons (Chapman University) · doi:10.36837/chapman.000424
Zukunftspotenziale der Labormedizin
Schlander, M., Schäfer, R., & Selberg, L. (2023) · Springer eBooks · doi:10.1007/978-3-662-66825-2_5
Artificial Intelligence and its Application in Healthcare Systems
Pradhan, D., Sahu, P. K., Tun, H. M., & Chatterjee, P. (2024) · doi:10.1002/9781394297443.ch1
Ananya, S., Suresh, N., & Pullela, P. K. (2024) · International Conference on Multimedia Processing, Communication & Information Technology (MPCIT) · doi:10.1109/mpcit62449.2024.10892672
Strategies for AI in Healthcare Implementation
Talukdar, J., Gogoi, D. K., & Sharma, R. (2025) · Studies in computational intelligence · doi:10.1007/978-3-031-80813-5_21
Health technology assessment of precision medicine: The living lab approach
Hawkins, N., & Wu, O. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95311-5.00007-5
An integrated review of additive manufacturing technologies and functional materials for medical use
Chari, V. S., Chand, R. P., Venkatesh, B., Prasad, M. G., Narendra, N., Pushpa, N., Hanumanthappa, H., & Shanmugam, B. K. (2025) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-025-00555-3
Munukutla, M. K., Karthikeyan, P., & Vishnu, M. (2025) · International Conference on New Frontiers in Communication, Automation, Management and Security (ICCAMS) · doi:10.1109/iccams65118.2025.11234626
Luo, X.-Y., Wu, K.-M., & He, X.-X. (2021) · Figshare · doi:10.6084/m9.figshare.14615275
Scholte, M., Coves, A. F., Yang, H., Armstrong, N., McDermott, K., Tian, X., Stirk, L., Wolff, R. A., Joore, M. A., & Grimm, S. E. (2026) · PharmacoEconomics · doi:10.1007/s40273-026-01591-7
Coves, A. F., Scholte, M., Emerson, J. R., Wolff, R., Abu-Zahra, T., Chen, J., McDermott, K., Armstrong, N., Joore, M. A., & Witlox, W. J. A. (2026) · PharmacoEconomics · doi:10.1007/s40273-026-01592-6
Baccolini, V., Siena, L. M., Isonne, C., Sciurti, A., Marzuillo, C., Vito, C. D., Torre, G. L., Arca, M., Migliara, G., & Villari, P. (2026) · Value in Health · doi:10.1016/j.jval.2026.03.004
Precision Medicine: Market and Its Potential in the Healthcare Industry
Kulkarni, M., & Sharma, M. (2025) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-83662-314-420251013
Farah, L. (2024) · theses.fr (ABES) · doi:10.70675/2826eff9z5f56z4a53za618z7d4afbe7e069
Wearables in Personalized and Precision Medicine
Almukhtar, Z., & Eappen, P. (2026) · Health informatics · doi:10.1007/978-3-032-23933-4_12
Modeling the economic equity of precision oncology
Tsatsou, I., & Fragkopoulos, S. (2026) · Journal of Current Health Sciences · doi:10.47679/jchs.2026168
Metadata
- Authors
- Love-Koh, J., Peel, A., Rejon-Parrilla, J. C., Ennis, K., Lovett, R., Manca, A., Chalkidou, A., Wood, H., & Taylor, M.
- Affiliations
- University of York (GB)
- University of Liverpool (GB)
- National Institute for Health and Care Excellence (GB)
- Luxembourg Institute of Health (LU)
- Corresponding author
- Love-Koh, James
- Venue
- PharmacoEconomics
- Published
- 2018-07-13
- Volume
- 36
- Issue
- 12
- Pages
- 1439-1451
- ISSN
- 1170-7690 (ISSN-L)
- 1179-2027
- PMC
- PMC6244622
- OpenAlex
- W2884983901
- Cited by
- 131
- References
- 53
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 17 · 2023: 25 · 2022: 16 · 2021: 28 · 2020: 15 · 2019: 11
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-10-26)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- PharmacoEconomics (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by-nc)
- Funders
- National Institute for Health and Care Excellence
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Technology and Human Factors in Education and Health
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- precision medicine, health technology assessment, patient stratification, digital health applications, artificial intelligence in healthcare, structural uncertainty, health care equity, value for money, decision-making
- MeSH terms
- Artificial Intelligence, Decision Making, Humans, Technology Assessment, Biomedical, Biomarkers, Biomedical Technology, Uncertainty, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
